Moreover, experiments in vitro showed that PRDX6 could regulate cell proliferation via JAK2-STAT3 signaling and involve the cell cycle process in BLCA, which may be more valuable for personalized treatment of cancer. Here, PRDX6 is linked to bladder transitional cell carcinoma.